Carol Feghali-Bostwick to Molecular Targeted Therapy
This is a "connection" page, showing publications Carol Feghali-Bostwick has written about Molecular Targeted Therapy.
Connection Strength
0.023
-
Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-?1 signaling. J Immunol. 2012 Sep 01; 189(5):2635-44.
Score: 0.023
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.